Komori
Dividends2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Notice Regarding Dividend of Surplus (Year-End Dividend)

The year-end dividend for the fiscal year ending March 2026 has been set at ¥30 per share. This is unchanged from the latest forecast and the previous fiscal year's actual dividend, bringing the annual dividend, including the interim dividend, to ¥50 per share.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
0
¥ per share
Wording
Conditional
How definitive the wording is.

Dividend per share

Fiscal year ending March 2026
50YenRevised annual dividend per sharePrevious forecast ¥50, change ¥0(0.0%)
Previous-period resultsPrevious forecastAfter revision

Each vertical step represents one dividend payment, and the total height of the accumulated steps represents the annual dividend for the period. For periods showing only the annual amount, the payment breakdown is not provided, so only the end point is plotted.

Dividend per shareyen¥30→¥300.0%
Total dividendsTotal amount payable to all shareholders¥1,248 million→¥1,248 million
Whether Submission to the General Meeting of Shareholders Is RequiredBoard of directors resolution only
Record date31 March 2026
Effective date29 June 2026

The record date is the cutoff date for determining which persons listed in the shareholder register on that date are entitled to receive dividends.Payments begin on the effective date.

Payout ratioTargeting a consolidated dividend payout ratio of 30–40%The percentage of earnings paid out as dividends.
Source of dividendsRetained earningsThe source of dividend payments. Depending on the type of surplus, the dividend may be paid from earned profits or may be closer to a return of capital.
Breakdown of Regular, Commemorative and Special DividendsOrdinary dividend only. There is no commemorative or special dividend component.
Dividend policy

The Company recognizes stable profit distributions to shareholders as one of its important management policies. Its basic policy is to determine dividends by taking into account basic earning power, cash flow and other factors, targeting a consolidated dividend payout ratio of 30–40%.

Dividend per share
ItemDetails
Dividend per share¥30.00 → ¥30.00(0%)
Total Annual Dividends¥50.00 → ¥50.00(0%)
Previous-period results (per share)Interim ¥20.00 / End of period ¥30.00 / Annual ¥50.00
Total dividends¥1,248 million → ¥1,248 million
Record date31 March 2026
Effective date29 June 2026
Source of dividendsRetained earnings
Breakdown of Regular, Commemorative and Special DividendsOrdinary dividend only. There is no commemorative or special dividend component.
Payout ratioTargeting a consolidated dividend payout ratio of 30–40%
Dividend policyThe Company recognizes stable profit distributions to shareholders as one of its important management policies. Its basic policy is to determine dividends by taking into account basic earning power, cash flow and other factors, targeting a consolidated dividend payout ratio of 30–40%.
Whether Submission to the General Meeting of Shareholders Is RequiredBoard of directors resolution only
Fiscal Period CoveredFiscal year ending March 2026

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Based on the policy of prioritizing stable profit distributions and determining dividends with reference to basic earning power and cash flow, targeting a consolidated dividend payout ratio of 30–40%. Although negotiations to partner "Atzumi™" were delayed during the fiscal year ending March 2026, operations progressed generally as planned otherwise, and the year-end dividend has therefore been set at ¥30 per share.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Dividend of Surplus (Year-End Dividend) | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori